Tumor suppressor and hepatocellular carcinoma

Martin, Juliette; Dufour, Jean-François; Fukui, Hirokazu
March 2008
World Journal of Gastroenterology;3/21/2008, Vol. 14 Issue 11, p1720
Academic Journal
A few signaling pathways are driving the growth of hepatocellular carcinoma. Each of these pathways possesses negative regulators. These enzymes, which normally suppress unchecked cell proliferation, are circumvented in the oncogenic process, either the over-activity of oncogenes is sufficient to annihilate the activity of tumor suppressors or tumor suppressors have been rendered ineffective. The loss of several key tumor suppressors has been described in hepatocellular carcinoma. Here, we systematically review the evidence implicating tumor suppressors in the development of hepatocellular carcinoma.


Related Articles

  • FBX8 Acts as an Invasion and Metastasis Suppressor and Correlates with Poor Survival in Hepatocellular Carcinoma. Wang, Feifei; Qiao, Yudan; Yu, Jiang; Ren, Xiaoli; Wang, Jianmei; Ding, Yi; Zhang, Xiaojing; Ma, Wenhui; Ding, Yanqing; Liang, Li // PLoS ONE;Jun2013, Vol. 8 Issue 6, p1 

    Background: F-box only protein 8 (FBX8), a novel component of F-box proteins, is lost in several cancers and has been associated with invasiveness of cancer cells. However, its expression pattern and role in the progression of hepatocellular carcinoma remain unclear. This study investigated the...

  • LFIRE-1/HFREP-1, a liver-specific gene, is frequently downregulated and has growth suppressor activity in hepatocellular carcinoma. Jun Yan; Yanlin Yu, David K.; Nan Wang; Yunchao Chang, David K.; Hao Ying; Weizhong Liu, David K.; Jin He; Shenqing Li, David K.; Wanli Jiang; Yuli Li, David K.; Huimin Liu; Hongyang Wang, David K.; Yonghua Xu, David K. // Oncogene;3/11/2004, Vol. 23 Issue 10, p1939 

    We have previously identified several novel genes, which are differentially expressed among human normal liver and hepatocellular carcinomas (HCCs). The full-length liver fibrinogen-related gene-1 (LFIRE-1) cDNA was cloned from the human normal liver cDNA library. LFIRE-1 is highly homologous to...

  • Hepatocellular carcinoma pathogenesis: from genes to environment. Farazi, Paraskevi A.; DePinho, Ronald A. // Nature Reviews Cancer;Sep2006, Vol. 6 Issue 9, p674 

    Hepatocellular carcinoma is among the most lethal and prevalent cancers in the human population. Despite its significance, there is only an elemental understanding of the molecular, cellular and environmental mechanisms that drive disease pathogenesis, and there are only limited therapeutic...

  • siRNA-Mediated β-Catenin Knockdown in Human Hepatoma Cells Results in Decreased Growth and Survival. Zeng, Gang; Apte, Udayan; Cieply, Benjamin; Singh, Sucha; Monga, Satdarshan P. S. // Neoplasia;Nov2007, Vol. 9 Issue 11, p951 

    β-Catenin, the chief oncogenic component of the canonical Wnt pathway, is known to be involved in a variety of cancers, including hepatocellular carcinoma (HCC). Although the mechanism of β-catenin activation in HCC is multifactorial, it is indisputably implicated at various stages of...

  • Loss of miR-532-5p in vitro promotes cell proliferation and metastasis by influencing CXCL2 expression in HCC. Xiaofei Song; Zie Wang; Yan Jin; Yong Wang; Wenbing Duan // American Journal of Translational Research;2015, Vol. 7 Issue 11, p2254 

    MicroRNAs (miRNAs) have been widely reported, which play important roles in cancer development. CXCL2 acts as an oncogene, however, its regulation by miRNAs is not clear in hepatocellular carcinoma (HCC). In our research, it is aimed to study the role of CXCL2 in HCC and the regulation of its...

  • Hdm2 is regulated by K-Ras and mediates p53-independent functions in pancreatic cancer cells. Sui, X.; Shin, S.; Zhang, R.; Firozi, P. F.; Yang, L.; Abbruzzese, J. L.; Reddy, S. A. G. // Oncogene;2/5/2009, Vol. 28 Issue 5, p709 

    There is emerging evidence that the oncogenic potential of hdm2 (human and/or murine double minute-2 protein) stems not only from its ability to counteract tumor suppressor p53 but also from its less understood p53-independent functions. Surprisingly, little is known about the role and...

  • Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors p16 and p27 in hepatocellular carcinoma. Matsuda, Yasunobu; Seng-Lai Tan // World Journal of Gastroenterology;3/21/2008, Vol. 14 Issue 11, p1734 

    Hepatocellular carcinoma (HCC) is one of the most common human cancers, and its incidence is still increasing in many countries. The prognosis of HCC patients remains poor, and identification of useful molecular prognostic markers is required. Many recent studies have shown that functional...

  • p53 Promotes proteasome-dependent degradation of oncogenic protein HBx by transcription of MDM2. Xian, Lingling; Zhao, Jing; Wang, Jia; Fang, Zhou; Peng, Bo; Wang, Wenzhang; Ji, Xiaona; Yu, Long // Molecular Biology Reports;Jul2010, Vol. 37 Issue 6, p2935 

    Hepatitis B virus X protein (HBx) is closely involved in the development of hepatocellular carcinoma (HCC). Tumor suppressor p53 was reported to induce HBx degradation and repress its oncogenic function recently, but the molecular mechanism is unknown. In this study, we attempted to identify the...

  • CHD1L: a novel oncogene. Wen Cheng; Yun Su; Feng Xu // Molecular Cancer;2013, Vol. 12 Issue 1, p1 

    Comprehensive sequencing efforts have revealed the genomic landscapes of common forms of human cancer and ~ 140 driver genes have been identified, but not all of them have been extensively investigated. CHD1L (chromodomain helicase/ATPase DNA binding protein 1- like gene) or ALC1 (amplified in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics